Clinical Outcomes of Younger Adults With Philadelphia-Negative Acute Lymphoblastic Leukemia, Treated With A Pediatric-Like Regimen Based on the GIMEMA LAL1308 Protocol. A Campus ALL Study.
Young adults with a common blood cancer respond well to pediatric treatment protocols, offering hope for improved survival in this age group.
INTRODUCTION: While pediatric-based protocols have significantly improved survival rates in adolescents and young adult (AYA) patients with Philadelphia-negative acute lymphoblastic leukemia (Ph- ALL), limited informatio... CONCLUSIONS: The implementation of this unmodified pediatric regimen to Ph- AYA ALL patients appears feasible in a real-life context, with results that compare favorably to those of other pediatric-based regimens not yet...
What the study was
- Study design
- Retrospective study
- Population
- patients, pediatric
- Category
- Treatment Innovation
- Maturity
- Exploratory
- Journal
- European journal of haematology
Why it surfaced
Score 7/10 [PROMISING_PRELIMINARY]: Retrospective study (Journal Article) matched 'Hematologic malignancies (AML, MDS, CLL,'. Components — novelty:1/3, relevance:3/3, design:1/2, population:2/2. Confidence: high. Conservative scoring applied per v1.3 rubric.
A plain-language summary of published research — not medical advice. Talk to a clinician about your own care.